This event will bring together leading experts and users of chiral technologies from India and abroad to deliberate on the present and future directions in this crucial technology.
It is known that modern drug development is predominantly based on chiral molecules. In the pharma industry over 85% of drugs are based on single optical isomers – a factor which has driven investments in chiral technologies. The requirements of chiral technologies change as a drug passes through different stages of the development pipeline. This calls for innovative approaches to chiral chemistries, separations and scale-up. One of the major challenges before the industry is to identify, evaluate and select the right chiral platform to invest in.
This event will provide a research and technology forum on chiral chemistries, technologies and instrumentation and assess the present and future directions of chiral technology in the Indian context.
- Global market for chiral technology to grow to $7.2 billion by 2016 (bccresearch.wordpress.com)
- Global Markets for Reagents for Chromatography — Focus on Liquid Chromatography (prnewswire.com)
- Healthcare India 2012 (indiahealthcarenews.wordpress.com)
- India signs Nagoya protocol ahead of Hyderabad CBD meet (spicyipindia.blogspot.com)
- Ghanaian delegation arrives in Hyderabad, India for COP 11 meeting (ghananewsagency.org)
- Biodiversity summit proposes update to UN Law of the Sea (radioaustralia.net.au)